Literature DB >> 22160333

The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding.

Robert William Platt1, Joseph Austin Christopher Delaney, Samy Suissa.   

Abstract

Estimates of the average causal effect (ACE) of warfarin on the risk of bleeding may be confounded by indication as patients at high risk of bleeding are unlikely to be prescribed warfarin. One approach to estimating the ACE is inverse probability of treatment weighting (IPTW). This study was designed to examine the use of IPTW in this setting, and to demonstrate problems with the violation of the positivity assumption. We analyzed a case-control study on 4,028 cases of gastro-intestinal bleeding and 79,239 controls set in the United Kingdom's General Practice Research Database. Warfarin exposure was defined as a prescription issued in the 90 days before the index date. Secondary analyses were conducted restricted to patients more likely to receive warfarin and with a truncated weight distribution, to exclude subjects highly unlikely to be treated. The estimated association between warfarin use and bleeding was stronger with IPTW [odds ratio (OR): 17.2; 95% confidence interval (CI): 6.5-37.7] than with a standard logistic regression model (OR: 2.1; 95% CI: 1.7-2.5). The presence of large weights (five subjects with stabilized weight >500) indicated a potential violation of the positivity assumption. In the restricted analysis, both IPTW (OR: 2.0; 95% CI: 0.4-9.6) and standard regression (OR: 1.6; 95% CI: 1.3-2.0) were compatible with a meta-analysis of randomized trials inverse probability of treatment weighting is sensitive to the positivity assumption; however, such sensitivity may assist in diagnosing off-support inference.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160333     DOI: 10.1007/s10654-011-9637-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  21 in total

1.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

Authors:  Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins
Journal:  Am J Epidemiol       Date:  2005-12-21       Impact factor: 4.897

2.  Estimability and estimation in case-referent studies.

Authors:  O Miettinen
Journal:  Am J Epidemiol       Date:  1976-02       Impact factor: 4.897

3.  On the estimation and use of propensity scores in case-control and case-cohort studies.

Authors:  Roger Månsson; Marshall M Joffe; Wenguang Sun; Sean Hennessy
Journal:  Am J Epidemiol       Date:  2007-05-15       Impact factor: 4.897

4.  The impact of unmeasured baseline effect modification on estimates from an inverse probability of treatment weighted logistic model.

Authors:  Joseph A C Delaney; Robert W Platt; Samy Suissa
Journal:  Eur J Epidemiol       Date:  2009-05-06       Impact factor: 8.082

5.  Comment: Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data.

Authors:  Anastasios A Tsiatis; Marie Davidian
Journal:  Stat Sci       Date:  2007       Impact factor: 2.901

6.  Invited commentary: positivity in practice.

Authors:  Daniel Westreich; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2010-02-05       Impact factor: 4.897

7.  The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database.

Authors:  Kristian B Filion; J A Chris Delaney; James M Brophy; Pierre Ernst; Samy Suissa
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-01       Impact factor: 2.890

8.  Issues in multiple imputation of missing data for large general practice clinical databases.

Authors:  Louise Marston; James R Carpenter; Kate R Walters; Richard W Morris; Irwin Nazareth; Irene Petersen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

9.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

10.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

View more
  8 in total

1.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

Review 2.  Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.

Authors:  Shibing Yang; Charles B Eaton; Juan Lu; Kate L Lapane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-01-24       Impact factor: 2.890

3.  Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction.

Authors:  Joseph A Delaney; Robin M Nance; Bridget M Whitney; Heidi M Crane; Jessica Williams-Nguyen; Mathew J Feinstein; Robert C Kaplan; David B Hanna; Matthew J Budoff; Daniel R Drozd; Greer Burkholder; Michael J Mugavero; William C Mathews; Richard D Moore; Joseph J Eron; Peter W Hunt; Elvin Geng; Michael S Saag; Mari M Kitahata; Susan R Heckbert
Journal:  Epidemiology       Date:  2019-01       Impact factor: 4.822

4.  Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort.

Authors:  Mohammad Ehsanul Karim; Paul Gustafson; John Petkau; Yinshan Zhao; Afsaneh Shirani; Elaine Kingwell; Charity Evans; Mia van der Kop; Joel Oger; Helen Tremlett
Journal:  Am J Epidemiol       Date:  2014-06-17       Impact factor: 4.897

5.  Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer.

Authors:  Adi J Klil-Drori; Koray Tascilar; Hui Yin; Armen Aprikian; Alain Bitton; Laurent Azoulay
Journal:  Am J Epidemiol       Date:  2016-06-06       Impact factor: 4.897

6.  Uncontrolled Pain and Risk for Depression and Behavioral Symptoms in Residents With Dementia.

Authors:  Yu-Jung Jenny Wei; Cheng Chen; Roger B Fillingim; Steven T DeKosky; Siegfried Schmidt; Marco Pahor; Laurence Solberg; Almut G Winterstein
Journal:  J Am Med Dir Assoc       Date:  2021-06-03       Impact factor: 7.802

7.  Augmented Weighted Estimators Dealing with Practical Positivity Violation to Causal inferences in a Random Coefficient Model.

Authors:  Mary Ying-Fang Wang; Paul Tuss; Lihong Qi
Journal:  Psychometrika       Date:  2019-03-15       Impact factor: 2.500

8.  Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.

Authors:  Md Belal Hossain; Lucy Mosquera; Mohammad Ehsanul Karim
Journal:  BMC Med Res Methodol       Date:  2022-02-16       Impact factor: 4.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.